Warner-Lambert to acquire $360 mil. Glaxo Wellcome OTC business for $1.05 bil..
This article was originally published in The Tan Sheet
Executive Summary
WARNER-LAMBERT's ACQUISITION OF $360 MIL. GLAXO WELLCOME OTC BUSINESS will give it the number-one position in the upper res-piratory products category in the U.S., Canada, Australia and the U.K., as well as the leading position in the first aid and lice treatments in the U.S., the company said. Warner-Lambert announced Dec. 19 that it has signed a letter of intent to acquire the Glaxo Wellcome OTC business for $1.05 bil.